These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 4399889)

  • 1. Circulatory responses to beta adrenergic blockade with alprenolol. Studies in patients with chronic heart disease.
    Kerber RE; Goldman RH; Alderman EL; Harrison DC
    Am J Cardiol; 1972 Jan; 29(1):26-32. PubMed ID: 4399889
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulatory effects of practolol.
    Finegan RE; Marlon AM; Harrison DC
    Am J Cardiol; 1972 Mar; 29(3):315-22. PubMed ID: 5060802
    [No Abstract]   [Full Text] [Related]  

  • 3. Central haemodynamic effects in man of intravenous d-alprenolol during rest and exercise.
    Ekelund LG; Melcher A; Orö L
    Eur J Clin Pharmacol; 1971 Sep; 3(4):198-203. PubMed ID: 5151303
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of alprenolol in acute cardiac arrhythmias.
    Lemberg L; Arcebal AG; Castellanos A; Slavin D
    Am J Cardiol; 1972 Jul; 30(1):77-81. PubMed ID: 4402503
    [No Abstract]   [Full Text] [Related]  

  • 5. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic changes at rest and during exercise in long-term beta-blocker therapy of essential hypertension.
    Lund-Johansen P
    Acta Med Scand; 1974; 195(1-2):117-21. PubMed ID: 4817079
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment.
    Sannerstedt R; Stenberg J; Vedin A; Wilhelmsson C; Werkö L
    Am J Cardiol; 1972 May; 29(5):718-23. PubMed ID: 4401785
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of atrial arrhythmias with alprenolol.
    Kerber RE; Goldman RH; Gianelly RE; Harrison DC
    JAMA; 1970 Dec; 214(10):1849-54. PubMed ID: 4396218
    [No Abstract]   [Full Text] [Related]  

  • 9. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodynamic effects of selective beta-adrenergic blockade during acute stage of myocardial infarction.
    Epois A; Rocha P; Roudy G; Bardet J; Bourdarias JP; Mathivat A
    Br Heart J; 1972 Dec; 34(12):1295-301. PubMed ID: 4405235
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of alprenolol on hemodynamics in angina pectoris.
    Cullhed I
    Acta Med Scand; 1973 May; 193(5):411-8. PubMed ID: 4717322
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemodynamic effects of practolol.
    Gibson DG; Coltart DJ
    Br Heart J; 1972 Jan; 34(1):95-9. PubMed ID: 4400624
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemodynamic effects of a cardioselective beta-adrenergic inhibitor (ICI 50172) in coronary insufficiency. Preliminary results].
    Rousseau M; Vandenput F; Brasseur L
    Acta Cardiol; 1972; ():Suppl 15:239-54. PubMed ID: 4404471
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic effects of a cardioselective beta-adrenergic inhibitor (ICI 50172) in coronary insufficiency. Preliminary results].
    Rosseau M; Vandenput F; Brasseur L
    Acta Cardiol; 1972; ():Suppl 15: 239-. PubMed ID: 4147615
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal].
    Bürgin D
    Schweiz Med Wochenschr; 1968 Jun; 98(25):940-5. PubMed ID: 5699197
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.
    Reynolds JL; Whitlock RM
    Br Heart J; 1972 Mar; 34(3):252-9. PubMed ID: 4111391
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic effects of practolol at rest and during exercise.
    Leon DF; Thompson ME; Shaver JA; McDonald RH
    Circulation; 1972 Jan; 45(1):46-54. PubMed ID: 4399771
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocardial and haemodynamic effects of the beta-adrenoceptor blocking drug alprenolol (H56/28) in anaesthetized cats.
    Parratt JR; Wadsworth RM
    Br J Pharmacol; 1969 Oct; 37(2):357-66. PubMed ID: 4390668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.